Dijous 11 de juny, el Dipòsit Digital no estarà operatiu de 15:00 a 17:00 h per tasques de manteniment. Disculpeu les molèsties.
El jueves 11 de Junio, el Dipòsit Digital no estará operativo de 15:00 a 17:00 h debido a tareas de mantenimiento. Disculpen las molestias.
Thursday, Jun 11th, the Digital Repository will be unavailable due to a system update.

Files

691114.pdf (798.35 KB)

Document type

Article

Version

Published version

Publication date

2019

Publication license

cc-by-nc-nd (c) Maghira & Maas , 2019
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/163049

Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

Abstract

In Spain it is necessary to conduct additional studies to determine place in therapy and cost-effectiveness of a drug. The main objective of this study is to identify all drug assessments and health technology assessment reports of the drugs for gastroenteropancreatic (GEP) neuroendocrine tumors (NET) at a national, regional and hospital level and to summarize the efficacy in terms of outcome measures, adverse events, economic impact and final recommendations.

Subject

Endocrinologia, Neurologia, Tumors

Subject (English)

Endocrinology, Neurology, Tumors

Citation

Collections

Articles publicats en revistes (Economia)

Citation

DARBÀ, Josep and ASCANIO, Meritxell. Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain. Neuroendocrinology Letters. 2019. Vol. 39, num. 8, pags. 537-543. ISSN 0172-780X. [consulted: 10 of June of 2026]. Available at: https://hdl.handle.net/2445/163049

Export metadata

JSON - METS

Share record